Edit |   |
---|---|
Antigenic Specificity | CD20, Human (Obinutuzumab biosimilar) |
Clone | Obinutuzumab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD20 Recombinant Antibody (Obinutuzumab). Obinutuzumab (called afutuzumab until 2009) is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. |
Immunogen | n/a |
Other Names | Anti-CD20 Recombinant Antibody, Research Grade Obinutuzumab, Anti-Human CD20 Recombinant Antibody(Obinutuzumab), GA101, RG7159, RO5072759, Antibody Drug Analogues, Monoclonal Antibody, YR1155, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 949142-50-1 |
Catalog # | YR1155 |
Price | please inquire |
Order / More Info | CD20, Human (Obinutuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |